IL-17 induces inflammation-associated gene products in blood monocytes, and treatment with ixekizumab reduces their expression in psoriasis patient blood. Article uri icon

Overview

publication date

  • July 7, 2014

Research

keywords

  • Antibodies, Monoclonal, Humanized
  • Cytokines
  • Interleukin-17
  • Monocytes
  • Psoriasis

Identity

Scopus Document Identifier

  • 84909948434

Digital Object Identifier (DOI)

  • 10.1038/jid.2014.268

PubMed ID

  • 24999591

Additional Document Info

volume

  • 134

issue

  • 12